USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
-
Market Cap
-
P/E Ratio
-
EPS
$33.70
52 Week High
$3.06
52 Week Low
HEALTHCARE
Sector
| Field | Value (ILS) |
|---|---|
| Total Assets | $3.3M |
| Total Current Assets | $2.8M |
| Cash And Cash Equivalents At Carrying Value | $2.4M |
| Cash And Short Term Investments | $2.4M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $450K |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | - |
| Other Non Current Assets | - |
| Total Liabilities | $32M |
| Total Current Liabilities | $32M |
| Current Accounts Payable | $2.1M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | - |
| Total Non Current Liabilities | $0 |
| Capital Lease Obligations | - |
| Long Term Debt | - |
| Current Long Term Debt | $28M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | - |
| Other Current Liabilities | - |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | -$29M |
| Treasury Stock | - |
| Retained Earnings | -$274M |
| Common Stock | - |
| Common Stock Shares Outstanding | $4.2M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Switzerland.